Causes of death in women with breast cancer: a risks and rates study on a population-based cohort.
breast cancer
cardio-oncology
cardiovascular disease
cause-specific death
competing-risk model
geographic variation
population-based cancer registries
respiratory disease
Journal
Frontiers in oncology
ISSN: 2234-943X
Titre abrégé: Front Oncol
Pays: Switzerland
ID NLM: 101568867
Informations de publication
Date de publication:
2023
2023
Historique:
received:
01
08
2023
accepted:
09
10
2023
medline:
29
11
2023
pubmed:
29
11
2023
entrez:
29
11
2023
Statut:
epublish
Résumé
The increasing survival of patients with breast cancer has prompted the assessment of mortality due to all causes of death in these patients. We estimated the absolute risks of death from different causes, useful for health-care planning and clinical prediction, as well as cause-specific hazards, useful for hypothesis generation on etiology and risk factors. Using data from population-based cancer registries we performed a retrospective study on a cohort of women diagnosed with primary breast cancer. We carried out a competing-cause analysis computing cumulative incidence functions (CIFs) and cause-specific hazards (CSHs) in the whole cohort, separately by age, stage and registry area. The study cohort comprised 12,742 women followed up for six years. Breast cancer showed the highest CIF, 13.71%, and cardiovascular disease was the second leading cause of death with a CIF of 3.60%. The contribution of breast cancer deaths to the CIF for all causes varied widely by age class: 89.25% in women diagnosed at age <50 years, 72.94% in women diagnosed at age 50-69 and 48.25% in women diagnosed at age ≥70. Greater CIF variations were observed according to stage: the contribution of causes other than breast cancer to CIF for all causes was 73.4% in women with stage I disease, 42.9% in stage II-III and only 13.2% in stage IV. CSH computation revealed temporal variations: in women diagnosed at age ≥70 the CSH for breast cancer was equaled by that for cardiovascular disease and "other diseases" in the sixth year following diagnosis, and an early peak for breast cancer was identified in the first year following diagnosis. Among women aged 50-69 we identified an early peak for breast cancer followed by a further peak near the second year of follow-up. Comparison by geographic area highlighted conspicuous variations: the highest CIF for cardiovascular disease was more than 70% higher than the lowest, while for breast cancer the highest CIF doubled the lowest. The integrated interpretation of absolute risks and hazards suggests the need for multidisciplinary surveillance and prevention using community-based, holistic and well-coordinated survivorship care models.
Identifiants
pubmed: 38023134
doi: 10.3389/fonc.2023.1270877
pmc: PMC10646497
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1270877Informations de copyright
Copyright © 2023 Contiero, Boffi, Borgini, Fabiano, Tittarelli, Mian, Vittadello, Epifani, Ardizzone, Cirilli, Boschetti, Marguati, Cascone, Tumino, Fanetti, Giumelli, Candela, Scuderi, Castelli, Bongiorno, Barigelletti, Perotti, Veronese, Turazza, Crivaro, Tagliabue and the MAPACA Working Group.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Arch Public Health. 2021 Jun 23;79(1):111
pubmed: 34162431
BMJ Open. 2016 Nov 14;6(11):e012580
pubmed: 28076275
Clin Cancer Res. 2012 Apr 15;18(8):2301-8
pubmed: 22282466
Springerplus. 2016 Jan 26;5:82
pubmed: 26844029
Lancet. 2014 Feb 8;383(9916):549-57
pubmed: 24351322
BMC Cancer. 2013 Dec 27;13:609
pubmed: 24373194
Nat Commun. 2020 Apr 24;11(1):2011
pubmed: 32332714
Cancer Epidemiol Biomarkers Prev. 2011 Oct;20(10):2120-6
pubmed: 21878589
J Clin Oncol. 2016 Aug 10;34(23):2743-9
pubmed: 27217451
Br J Cancer. 2004 Oct 4;91(7):1229-35
pubmed: 15305188
J Clin Med. 2020 Jun 10;9(6):
pubmed: 32532011
Circulation. 2016 Feb 9;133(6):601-9
pubmed: 26858290
Int J Radiat Oncol Biol Phys. 2006 Mar 15;64(4):1081-91
pubmed: 16446057
Front Cardiovasc Med. 2022 Apr 13;9:784409
pubmed: 35498020
Am J Epidemiol. 2009 Jul 15;170(2):244-56
pubmed: 19494242
J Natl Cancer Inst. 2015 Nov 26;108(5):
pubmed: 26614095
Int J Environ Res Public Health. 2022 Dec 27;20(1):
pubmed: 36612726
Clin Transl Oncol. 2019 Aug;21(8):1014-1025
pubmed: 30607790
J Clin Oncol. 2008 Aug 20;26(24):4027-34
pubmed: 18711194
Eur Heart J. 2018 Nov 14;39(43):3896-3903
pubmed: 29635274
Cancer Causes Control. 2009 Jul;20(5):533-8
pubmed: 19015942
Eur Heart J. 2014 Nov 7;35(42):2936-41
pubmed: 24711436
J Clin Oncol. 2011 Oct 20;29(30):4014-21
pubmed: 21911717
Lancet. 2018 Mar 17;391(10125):1023-1075
pubmed: 29395269
J Natl Cancer Inst. 2021 Feb 1;113(2):137-145
pubmed: 32634223
Breast Cancer Res. 2011 Jun 20;13(3):R64
pubmed: 21689398
Breast Cancer Res Treat. 2017 Aug;164(3):537-555
pubmed: 28503723
Cancer. 2020 Apr 1;126(7):1559-1567
pubmed: 31840240
J Oncol Pract. 2015 Jan;11(1):e19-27
pubmed: 25205779
Medicina (Kaunas). 2020 Sep 12;56(9):
pubmed: 32932597
JNCI Cancer Spectr. 2023 Jan 3;7(1):
pubmed: 36445023
Breast Cancer Res Treat. 1996;41(2):177-85
pubmed: 8944336
J Clin Epidemiol. 2013 Jun;66(6):648-53
pubmed: 23415868
Support Care Cancer. 2018 Jul;26(7):2125-2141
pubmed: 29696424
JAMA Cardiol. 2017 Jan 1;2(1):88-93
pubmed: 27732702
Int J Integr Care. 2018 Oct 12;18(4):2
pubmed: 30483035
Bone Marrow Transplant. 2010 Sep;45(9):1388-95
pubmed: 20062101
Cancers (Basel). 2021 Apr 16;13(8):
pubmed: 33923380